Condensed Consolidated Interim Statements of Changes in Shareholders' Equity (Deficiency) - USD ($)
|
Total |
Preferred Stock [Member] |
Common Stock [Member] |
Additional Paid-in Capital [Member] |
Deficit [Member] |
Accumulated Other Comprehensive Income [Member] |
| Opening Balance at Mar. 31, 2016 |
$ 5,399,851
|
$ 0
|
$ 72,591
|
$ 18,292,173
|
$ (13,007,062)
|
$ 42,149
|
| Opening Balance (in shares) at Mar. 31, 2016 |
|
1
|
72,591,292
|
|
|
|
| Shares issued to acquire IMT |
23,177,000
|
$ 0
|
$ 23,650
|
23,153,350
|
0
|
0
|
| Shares issued to acquire IMT (in shares) |
|
|
23,650,000
|
|
|
|
| Stock compensation acquired |
2,582,890
|
0
|
$ 0
|
2,582,890
|
0
|
0
|
| Options exercised |
18,166
|
0
|
$ 110
|
18,056
|
0
|
0
|
| Options exercised (in shares) |
|
|
110,096
|
|
|
|
| Warrant exercised |
40,195
|
0
|
$ 175
|
40,020
|
0
|
0
|
| Warrant exercised (in shares) |
|
|
174,759
|
|
|
|
| Share compensation expense |
1,001,950
|
0
|
$ 217
|
1,001,733
|
0
|
0
|
| Share compensation expense (in shares) |
|
|
217,047
|
|
|
|
| Cashless exercise of warrants (Note 2) |
0
|
0
|
$ 51
|
(51)
|
0
|
0
|
| Cashless exercise of warrants (Note 2) (in shares) |
|
|
51,249
|
|
|
|
| Net loss for the year |
(8,069,402)
|
0
|
$ 0
|
0
|
(8,069,402)
|
0
|
| Closing Balance at Mar. 31, 2017 |
24,150,650
|
$ 0
|
$ 96,794
|
45,088,171
|
(21,076,464)
|
42,149
|
| Closing Balance (in shares) at Mar. 31, 2017 |
|
1
|
96,794,443
|
|
|
|
| Warrant exercised |
1,125,038
|
$ 0
|
$ 5,000
|
1,120,038
|
0
|
0
|
| Warrant exercised (in shares) |
|
|
5,000,172
|
|
|
|
| Share compensation expense |
251,048
|
0
|
$ 0
|
251,048
|
0
|
0
|
| Fair value of warrants on convertible loans |
204,790
|
0
|
|
204,790
|
0
|
0
|
| Net loss for the year |
(2,240,518)
|
0
|
0
|
0
|
(2,240,518)
|
0
|
| Closing Balance at Jun. 30, 2017 |
23,491,008
|
$ 0
|
$ 101,794
|
46,664,047
|
(23,316,982)
|
42,149
|
| Closing Balance (in shares) at Jun. 30, 2017 |
|
1
|
101,794,615
|
|
|
|
| Opening Balance at Mar. 31, 2017 |
24,150,650
|
$ 0
|
$ 96,794
|
45,088,171
|
(21,076,464)
|
42,149
|
| Opening Balance (in shares) at Mar. 31, 2017 |
|
1
|
96,794,443
|
|
|
|
| Warrant exercised |
1,125,038
|
$ 0
|
$ 5,000
|
1,120,038
|
0
|
0
|
| Warrant exercised (in shares) |
|
|
5,000,172
|
|
|
|
| Share compensation expense |
1,540,580
|
0
|
$ 0
|
1,540,580
|
0
|
0
|
| Fair value of warrants on convertible loans |
548,179
|
0
|
0
|
548,179
|
0
|
0
|
| Warrant down-round feature |
0
|
0
|
0
|
74,086
|
(74,086)
|
0
|
| Conversion of convertible notes |
9,180,785
|
0
|
$ 147,805
|
9,032,980
|
0
|
0
|
| Conversion of convertible notes (in shares) |
|
|
147,805,371
|
|
|
|
| Stock option and warrant reclassification (Notes 11 & 12) |
(2,845,557)
|
0
|
$ 0
|
(2,845,557)
|
0
|
0
|
| Beneficial conversion feature on convertible debt (Note 8) |
(1,389,129)
|
0
|
0
|
1,389,129
|
|
0
|
| Net loss for the year |
(14,625,790)
|
0
|
0
|
0
|
(14,625,790)
|
|
| Closing Balance at Mar. 31, 2018 |
20,463,014
|
$ 0
|
$ 249,599
|
55,947,606
|
(35,776,340)
|
42,149
|
| Closing Balance (in shares) at Mar. 31, 2018 |
|
1
|
249,599,986
|
|
|
|
| Opening Balance at Jun. 30, 2017 |
23,491,008
|
$ 0
|
$ 101,794
|
46,664,047
|
(23,316,982)
|
42,149
|
| Opening Balance (in shares) at Jun. 30, 2017 |
|
1
|
101,794,615
|
|
|
|
| Share compensation expense |
1,289,532
|
|
|
1,289,532
|
|
|
| Share compensation expense (in shares) |
|
0
|
|
|
|
|
| Fair value of warrants on convertible loans |
343,389
|
|
|
343,389
|
|
|
| Warrant down-round feature |
0
|
$ 0
|
$ 0
|
74,086
|
(74,086)
|
0
|
| Conversion of convertible notes |
9,180,785
|
0
|
$ 147,805
|
9,032,980
|
0
|
0
|
| Conversion of convertible notes (in shares) |
|
|
147,805,371
|
|
|
|
| Stock option and warrant reclassification (Notes 11 & 12) |
(2,845,557)
|
0
|
$ 0
|
(2,845,557)
|
0
|
0
|
| Beneficial conversion feature on convertible debt (Note 8) |
1,389,129
|
0
|
0
|
1,389,129
|
0
|
0
|
| Net loss for the year |
(12,385,272)
|
0
|
0
|
0
|
(12,385,272)
|
0
|
| Closing Balance at Mar. 31, 2018 |
20,463,014
|
$ 0
|
$ 249,599
|
55,947,606
|
(35,776,340)
|
42,149
|
| Closing Balance (in shares) at Mar. 31, 2018 |
|
1
|
249,599,986
|
|
|
|
| Share compensation expense |
595,412
|
$ 0
|
|
595,412
|
0
|
0
|
| Conversion of convertible notes |
2,470,622
|
0
|
$ 39,546
|
2,431,076
|
0
|
0
|
| Conversion of convertible notes (in shares) |
|
|
39,545,776
|
|
|
|
| Stock option and warrant reclassification (Notes 11 & 12) |
1,173,534
|
0
|
$ 0
|
1,173,534
|
0
|
0
|
| Net loss for the year |
(760,698)
|
0
|
0
|
0
|
(760,698)
|
0
|
| Closing Balance at Jun. 30, 2018 |
$ 23,941,884
|
$ 0
|
$ 289,145
|
$ 60,147,628
|
$ (36,537,038)
|
$ 42,149
|
| Closing Balance (in shares) at Jun. 30, 2018 |
|
1
|
289,145,762
|
|
|
|